Why Did OSCR Stock Gain Pre-Market After Earnings?
Synopsis
The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025.
Oscar Health (OSCR) shares rebounded from early losses to rise more than 5% in pre-market trading on Tuesday after the company projected fiscal 2026 revenue well above the FY2025 level reported alongside its fourth-quarter results.
Q4 total revenue came in at $2.81 billion, significantly below the Street estimates of $3.12 billion, according to Fiscal.ai data. The company reported a loss of $1.24 per share, wider than the estimates of a loss of $0.92 per share.
The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025. Oscar Health also expects earnings from operations between $250 and $450 million in FY2026.
Read updates to this developing story on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.